Skip to main content

pregnancy Archives

Targeted cancer drug during pregnancy

Aug. 2, 2022—The targeted cancer therapy alectinib was safe as a treatment for lung cancer during two pregnancies in a patient with non-small cell lung cancer, according to a case report from Vanderbilt physicians.

Read more


Study shows two vaccine doses for mothers eases COVID complications for infants

Jul. 6, 2022—Infants younger than 6 months were better protected from COVID-19 complications when mothers received two doses of the vaccine while pregnant, according to Vanderbilt researchers.

Read more


Rheumatoid arthritis: special deliveries

Mar. 28, 2022—Birth outcomes including postpartum infection and blood transfusion were similar in women with and without rheumatoid arthritis, and continued use of disease-modifying antirheumatic drugs and biologics is recommended to limit steroid exposure.

Read more


Invasive strep can defy zinc toxicity

Feb. 28, 2022—Vanderbilt researchers find that invasive Group B Streptococcus strains, a significant risk to pregnant patients and infants, can grow in presence of toxic zinc levels.

Read more


Common questions about COVID vaccine and pregnancy

Nov. 15, 2021—  Recently, Vanderbilt University Medical Center’s Chief Epidemiologist, Dr. Tom Talbot, sat down to speak with his colleague Dr. Milner Staub, one of VUMC’s Adult Infectious Diseases specialists, about COVID vaccines, pregnancy and fertility. Staub, who is pregnant and has been vaccinated for COVID, answered important questions about issues and misperceptions associated with pregnancy and...

Read more


HCV infection among pregnant people increasing

Oct. 29, 2021—  by Emily Stembridge Hepatitis C virus (HCV) infection can lead to long-term health problems including liver damage, liver failure, cirrhosis, liver cancer and even death. These outcomes are especially dangerous for pregnant people and their babies. The leading cause of HCV in the U.S. is injection drug use as a result of opioid use...

Read more


Fibroids and preterm birth

Sep. 30, 2021—In a large, prospective study, Vanderbilt researchers found no association between fibroids and any clinical subtype of preterm birth, supporting a reconsideration of the impression that fibroids increase preterm birth risk.

Read more


Alarming number of pregnant COVID-19 patients hospitalized in August

Sep. 1, 2021—Vanderbilt University Hospital treated 39 pregnant patients hospitalized with active COVID-19 infections in August, 10 of whom were admitted to the intensive care unit (ICU).

Read more


VUMC sees increase of COVID-19 in pregnant patients

Aug. 2, 2021—Physicians at Vanderbilt University Medical Center (VUMC) have recently noticed an increase in pregnant patients ill with COVID-19. These cases are especially concerning due an increased risk of hospitalization, ICU admission, need for mechanical ventilation and ventilatory support, and increased risk of death in pregnant patients with COVID-19 compared to non-pregnant patients.

Read more


Fibroids and birth outcomes

Sep. 8, 2020—Women with three or more uterine fibroids — non-cancerous growths — during pregnancy are more likely to have infants with reduced birthweight and may need additional surveillance.

Read more


Study finds patients’ access to opioid treatment cumbersome

Aug. 14, 2020—Women are having a difficult time getting into treatment for opioid addictions, according to a Vanderbilt University Medical Center study published today in JAMA Open.

Read more


Miscarriage risk increases each week alcohol is used in early pregnancy

Aug. 10, 2020—Each week a woman consumes alcohol during the first five to 10 weeks of pregnancy is associated with an incremental 8% increase in risk of miscarriage, according to a study published this week by Vanderbilt University Medical Center researchers.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more